Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain ...Middle East

Medscape - News
The HIF prolyl hydroxylase inhibitor shows efficacy in the treatment of anemia with chronic kidney disease, but in non-dialysis patients increased cardiovascular risks are observed. Medscape Medical News

Hence then, the article about vadadustat for anemia in chronic kidney disease questions remain was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News